etilefrine pivalate

Known as: (+-)-m-((Ethylamino)-1-hydroxyethyl)phenyl Pivalate, K 30 052 
A prodrug of etilefrine, an adrenergic agonist with vasoconstrictive activity. Etilefrine pivalate is hydrolyzed to etilefrine, which binds to and… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1965-2017
024619652017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
BACKGROUND There is little information regarding the risk of sensitization associated with topical atopic dermatitis (AD… (More)
Is this relevant?
2008
2008
Topical corticosteroids are first-line treatments for atopic dermatitis (AD) and their efficacy is well-established in randomized… (More)
Is this relevant?
2003
2003
This study was designed to evaluate the safety and efficacy of concomitant therapy with the corticosteroid clocortolone pivalate… (More)
Is this relevant?
2001
2001
Thimerosal, a mercuric derivative of thiosalicylic acid, is a preservative used in several types of consumer products, including… (More)
Is this relevant?
1996
1996
The correct concentration and vehicle for patch testing with corticosteroids is in many instances not known. The results of this… (More)
Is this relevant?
1995
1995
BACKGROUND AND DESIGN Most corticosteroid-allergic patients react to several corticosteroids. Irrefutable proof for the existence… (More)
Is this relevant?
1993
1993
Endothelin-1 (ET-1) is known as a vasoconstrictor peptide. However, recent reports suggested the effects on the transport of… (More)
Is this relevant?
1988
1988
We analyzed angiotensin II (ANG II) receptors by in vitro autoradiography in selective brain nuclei of control, salt-treated (1… (More)
Is this relevant?
1987
1987
The stress response involves activation of the hypothalamic-pituitary adrenal axis and the sympathetic nervous system. To study… (More)
Is this relevant?
1985
1985
In a double-blind trial of 3 months 24 hypotensive patients suffering from migraine were treated with etilefrine pivalate (K 30… (More)
Is this relevant?